Cell therapy pioneer Dr. Carl June to chair Chinese biotech firm's scientific advisory board
October 21, 2021 at 12:06 PM EDT
June led the team at Penn that developed the first FDA-approved CAR-T cell therapy to treat acute lymphoblastic leukemia.
